ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang provided an update regarding the company and its CBD Biotech subsidiary in a recent SmallCapVoice.com interview (http://cnw.fm/v1kML). An article discussing the company reads, “In the interview, Wang explains the enormous market opportunity in China for CBD/hemp-infused cosmetic products, such as lotion and anti-aging cream. . . . While the sale of hemp and CBD oil in cosmetics is permitted, China has not yet approved these products for use in food or medicine; however, given worldwide legalization trends, this is likely to change in the near future. CBD Biotech is an early player in China’s CBD sector, and Wang is optimistic about the company’s future in the promising market. ‘CBD-infused or hemp-infused cosmetic products [are] still very early stage in China,’ he said. ‘We are only one of few players in the market, and I think 2020 will give us a lot of opportunities.’”
To view the full article, visit http://cnw.fm/KDS7u
About ChineseInvestors.com Inc.
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.